Inhibitors compounds of the flavivirus replication process.

Leidy L García, Leonardo Padilla, Jhon C Castaño
Author Information
  1. Leidy L García: Group of Molecular Immunology, Universidad del Quindío, Armenia (Quindío), Colombia. llgarciaa@uqvirtual.edu.co.
  2. Leonardo Padilla: Group of Molecular Immunology, Universidad del Quindío, Armenia (Quindío), Colombia.
  3. Jhon C Castaño: Group of Molecular Immunology, Universidad del Quindío, Armenia (Quindío), Colombia.

Abstract

Flaviviruses are small viruses with single-stranded RNA, which include the yellow fever virus, dengue virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis virus, and Zika virus; and are causal agents of the most important emerging diseases that have no available treatment to date. In recent years, the strategy has focused on the development of replication inhibitors of these viruses designed to act mainly by affecting the activity of enzyme proteins, such as NS3 and NS5, which perform important functions in the viral replication process. This article describes the importance of flaviviruses and the development of molecules used as inhibitors of viral replication in this genus.

Keywords

References

  1. Mol Biotechnol. 2016 Dec;58(12 ):801-806 [PMID: 27683255]
  2. Antiviral Res. 2013 Sep;99(3):301-6 [PMID: 23769930]
  3. Antiviral Res. 2010 Sep;87(3):281-94 [PMID: 20452379]
  4. Antiviral Res. 2010 Mar;85(3):450-62 [PMID: 20060421]
  5. J Virol. 2010 Jun;84(11):5678-86 [PMID: 20237086]
  6. Antiviral Res. 2009 Jun;82(3):95-102 [PMID: 19428599]
  7. Antiviral Res. 2013 May;98(2):242-7 [PMID: 23470860]
  8. Virus Res. 2014 Jun 24;185:32-40 [PMID: 24657789]
  9. Antiviral Res. 2014 Jun;106:125-34 [PMID: 24680954]
  10. Vaccine. 2012 Jun 19;30(29):4301-6 [PMID: 22682286]
  11. Virus Res. 2012 Jun;166(1-2):68-76 [PMID: 22445690]
  12. Biochim Biophys Acta. 2014 Sep;1838(9):2180-97 [PMID: 24780375]
  13. Arch Virol. 2014 Mar;159(3):573-9 [PMID: 24081825]
  14. Antiviral Res. 2015 Feb;114:67-85 [PMID: 25512228]
  15. PLoS Pathog. 2016 Aug 08;12(8):e1005737 [PMID: 27500641]
  16. Curr Opin Virol. 2014 Dec;9:134-42 [PMID: 25462445]
  17. Virology. 2011 Sep 1;417(2):369-78 [PMID: 21767858]
  18. EMBO J. 2008 Dec 3;27(23):3209-19 [PMID: 19008861]
  19. Front Cell Infect Microbiol. 2016 Nov 04;6:144 [PMID: 27867910]
  20. N Engl J Med. 2015 Jan 8;372(2):113-23 [PMID: 25365753]
  21. Biochem Pharmacol. 2017 Apr 1;129:14-25 [PMID: 28104437]
  22. Bioorg Med Chem. 2011 Jul 1;19(13):4067-74 [PMID: 21641807]
  23. Antiviral Res. 2013 Nov;100(2):446-54 [PMID: 24084488]
  24. ACS Infect Dis. 2015 Mar 13;1(3):140-148 [PMID: 26029739]
  25. J Biol Chem. 2011 Apr 22;286(16):14362-72 [PMID: 21349834]
  26. Antiviral Res. 2011 Feb;89(2):127-35 [PMID: 21185332]
  27. Antiviral Res. 2013 Nov;100(2):500-19 [PMID: 24076358]
  28. Antimicrob Agents Chemother. 2010 Jul;54(7):2932-9 [PMID: 20457821]
  29. Virology. 2009 Feb 5;384(1):242-52 [PMID: 19062063]
  30. Eur J Med Chem. 2013 Jul;65:249-55 [PMID: 23721953]
  31. PLoS Negl Trop Dis. 2016 May 10;10 (5):e0004695 [PMID: 27163257]
  32. Antiviral Res. 1990 Mar;13(3):139-49 [PMID: 2353804]
  33. Antiviral Res. 2015 Jun;118:68-74 [PMID: 25823617]
  34. Antiviral Res. 2013 May;98(2):192-208 [PMID: 23523765]
  35. EBioMedicine. 2016 Oct;12 :156-160 [PMID: 27658737]
  36. Farmaco. 2001 Jan-Feb;56(1-2):33-6 [PMID: 11347963]
  37. Antiviral Res. 2010 Aug;87(2):213-22 [PMID: 20470829]
  38. Virus Res. 2009 Feb;139(2):230-9 [PMID: 18703097]
  39. Antiviral Res. 2017 Apr;140:25-36 [PMID: 28041959]
  40. Antiviral Res. 2009 Oct;84(1):48-59 [PMID: 19589358]
  41. Eur J Med Chem. 2014 Jun 10;80:579-92 [PMID: 24835816]
  42. Antiviral Res. 2015 Jun;118:39-45 [PMID: 25796970]
  43. Antiviral Res. 2008 Oct;80(1):1-10 [PMID: 18571739]
  44. Eur J Med Chem. 2014 Apr 9;76:98-109 [PMID: 24583349]
  45. Eur J Med Chem. 2014 Nov 24;87:529-39 [PMID: 25285371]
  46. J Virol. 2007 May;81(9):4753-65 [PMID: 17301146]
  47. Antiviral Res. 2008 Oct;80(1):23-35 [PMID: 18611413]
  48. Biochem Biophys Res Commun. 2013 May 17;434(4):767-72 [PMID: 23587903]
  49. Curr Opin Virol. 2013 Oct;3(5):508-13 [PMID: 24070806]
  50. Antiviral Res. 2010 Aug;87(2):125-48 [PMID: 19945487]
  51. Methods. 2011 Oct;55(2):166-71 [PMID: 21855635]
  52. Antiviral Res. 2009 Jan;81(1):6-15 [PMID: 18796313]
  53. Open Forum Infect Dis. 2016 Aug 30;3(4):ofw175 [PMID: 27747251]
  54. ACS Chem Biol. 2008 Dec 19;3(12):765-75 [PMID: 19053243]
  55. PLoS Pathog. 2016 Feb 19;12(2):e1005451 [PMID: 26895240]
  56. Antiviral Res. 2008 Oct;80(1):11-22 [PMID: 18585795]
  57. Antiviral Res. 2011 Jan;89(1):26-34 [PMID: 21073903]
  58. Antiviral Res. 2017 Feb;138:47-56 [PMID: 27919709]
  59. Antimicrob Agents Chemother. 2014;58(1):110-9 [PMID: 24145533]
  60. PLoS One. 2012;7(11):e50995 [PMID: 23226444]
  61. Antiviral Res. 2013 Aug;99(2):165-71 [PMID: 23735301]
  62. Biochem Biophys Res Commun. 2014 Oct 24;453(3):539-44 [PMID: 25281902]
  63. J Antimicrob Chemother. 2012 Aug;67(8):1884-94 [PMID: 22535622]
  64. Antimicrob Agents Chemother. 2013 Jan;57(1):15-25 [PMID: 23070172]
  65. Antiviral Res. 2015 Jun;118:148-58 [PMID: 25842996]
  66. Antiviral Res. 2014 May;105:8-16 [PMID: 24561230]
  67. Antiviral Res. 2015 Jul;119:57-67 [PMID: 25912817]
  68. Antiviral Res. 2008 Nov;80(2):94-101 [PMID: 18674567]
  69. Virology. 2008 Oct 25;380(2):276-84 [PMID: 18757072]
  70. J Biol Chem. 2013 Oct 25;288(43):31105-14 [PMID: 24025331]

MeSH Term

Antiviral Agents
Drug Discovery
Flaviviridae
Flaviviridae Infections
Humans
Virus Replication

Chemicals

Antiviral Agents

Word Cloud

Created with Highcharts 10.0.0virusreplicationvirusesencephalitisimportantdevelopmentinhibitorsNS5viralprocessInhibitorsFlavivirusessmallsingle-strandedRNAincludeyellowfeverdengueWestNileJapanesetick-borneZikacausalagentsemergingdiseasesavailabletreatmentdaterecentyearsstrategyfocuseddesignedactmainlyaffectingactivityenzymeproteinsNS3performfunctionsarticledescribesimportanceflavivirusesmoleculesusedgenuscompoundsflavivirusFlavivirusprotein

Similar Articles

Cited By (32)